CA2498636C - Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals - Google Patents
Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals Download PDFInfo
- Publication number
- CA2498636C CA2498636C CA2498636A CA2498636A CA2498636C CA 2498636 C CA2498636 C CA 2498636C CA 2498636 A CA2498636 A CA 2498636A CA 2498636 A CA2498636 A CA 2498636A CA 2498636 C CA2498636 C CA 2498636C
- Authority
- CA
- Canada
- Prior art keywords
- protein
- yeast cell
- yeast
- polynucleotide
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Diabetes (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Toxicology (AREA)
- Emergency Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Plant Pathology (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Botany (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10242763A DE10242763A1 (de) | 2002-09-14 | 2002-09-14 | Verwendung von Saccharomyces cerevisiae erg4-Mutanten zur Expression von Glukosetransportern aus Säugetieren |
DE10242763.1 | 2002-09-14 | ||
PCT/EP2003/009812 WO2004026907A2 (de) | 2002-09-14 | 2003-09-04 | Verwendung von saccharomyces cerevisiae erg4-mutanten zur expression von glukosetransportern aus säugetieren |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2498636A1 CA2498636A1 (en) | 2004-04-01 |
CA2498636C true CA2498636C (en) | 2012-04-17 |
Family
ID=31724774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2498636A Expired - Fee Related CA2498636C (en) | 2002-09-14 | 2003-09-04 | Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1539958A2 (ko) |
JP (1) | JP4520854B2 (ko) |
KR (1) | KR101233998B1 (ko) |
CN (1) | CN1694960B (ko) |
AU (1) | AU2003264257B2 (ko) |
BR (1) | BR0314115A (ko) |
CA (1) | CA2498636C (ko) |
DE (1) | DE10242763A1 (ko) |
HK (1) | HK1084401A1 (ko) |
IL (2) | IL167321A (ko) |
MX (1) | MXPA05002816A (ko) |
NO (1) | NO20051795L (ko) |
RU (1) | RU2345136C2 (ko) |
WO (1) | WO2004026907A2 (ko) |
ZA (1) | ZA200501871B (ko) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102899328A (zh) * | 2012-09-28 | 2013-01-30 | 南京农业大学 | 山羊葡萄糖转运载体4基因及其重组表达载体和应用 |
CN110408616B (zh) * | 2019-07-09 | 2021-06-15 | 中南民族大学 | GLUT4基因敲除的sgRNA、A549细胞系及其构建方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5942398A (en) * | 1998-02-26 | 1999-08-24 | Millennium Pharmaceuticals, Inc. | Nucleic acid molecules encoding glutx and uses thereof |
WO2000075188A1 (en) * | 1999-06-09 | 2000-12-14 | Whitehead Institute For Biomedical Research | Method of measuring plasma membrane targeting of glut4 |
DE10106718A1 (de) * | 2001-02-14 | 2002-09-05 | Aventis Pharma Gmbh | Hefestamm von Saccharomyces cerevisiae mit funktioneller Expression eines Glut-Transporters |
-
2002
- 2002-09-14 DE DE10242763A patent/DE10242763A1/de not_active Withdrawn
-
2003
- 2003-09-04 CA CA2498636A patent/CA2498636C/en not_active Expired - Fee Related
- 2003-09-04 WO PCT/EP2003/009812 patent/WO2004026907A2/de active Application Filing
- 2003-09-04 BR BR0314115-2A patent/BR0314115A/pt not_active IP Right Cessation
- 2003-09-04 JP JP2004536979A patent/JP4520854B2/ja not_active Expired - Fee Related
- 2003-09-04 CN CN038251485A patent/CN1694960B/zh not_active Expired - Fee Related
- 2003-09-04 RU RU2005110955/13A patent/RU2345136C2/ru not_active IP Right Cessation
- 2003-09-04 KR KR1020057004292A patent/KR101233998B1/ko not_active IP Right Cessation
- 2003-09-04 EP EP03797264A patent/EP1539958A2/de not_active Withdrawn
- 2003-09-04 MX MXPA05002816A patent/MXPA05002816A/es active IP Right Grant
- 2003-09-04 AU AU2003264257A patent/AU2003264257B2/en not_active Ceased
-
2005
- 2005-03-04 ZA ZA2005/01871A patent/ZA200501871B/en unknown
- 2005-03-08 IL IL167321A patent/IL167321A/en not_active IP Right Cessation
- 2005-04-12 NO NO20051795A patent/NO20051795L/no not_active Application Discontinuation
-
2006
- 2006-04-18 HK HK06104586.6A patent/HK1084401A1/xx not_active IP Right Cessation
-
2009
- 2009-03-16 IL IL197621A patent/IL197621A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2003264257A1 (en) | 2004-04-08 |
IL167321A (en) | 2013-11-28 |
IL197621A0 (en) | 2011-08-01 |
AU2003264257B2 (en) | 2010-05-20 |
MXPA05002816A (es) | 2005-05-27 |
ZA200501871B (en) | 2005-10-26 |
WO2004026907A2 (de) | 2004-04-01 |
WO2004026907A3 (de) | 2004-11-11 |
JP4520854B2 (ja) | 2010-08-11 |
RU2005110955A (ru) | 2006-01-20 |
CN1694960A (zh) | 2005-11-09 |
CN1694960B (zh) | 2010-05-12 |
IL197621A (en) | 2014-01-30 |
DE10242763A1 (de) | 2004-03-18 |
BR0314115A (pt) | 2005-07-12 |
JP2006517088A (ja) | 2006-07-20 |
CA2498636A1 (en) | 2004-04-01 |
RU2345136C2 (ru) | 2009-01-27 |
KR20050056206A (ko) | 2005-06-14 |
NO20051795L (no) | 2005-06-08 |
EP1539958A2 (de) | 2005-06-15 |
HK1084401A1 (en) | 2006-07-28 |
KR101233998B1 (ko) | 2013-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6232458B1 (en) | Synthetic polynucleotides encoding tropoelastin | |
KR102684387B1 (ko) | 신규한 마이크로-디스트로핀 및 관련된 사용 방법 | |
DK3087178T3 (en) | PROCEDURE FOR PREPARING OXALATE OXIDASES WITH ACTIVITY OPTIMUM NEAR PHYSIOLOGICAL PH AND APPLICATION OF SUCH RECOMBINANT OXALATE OXIDASES IN THE TREATMENT OF OXALATE-RELATED DISEASES | |
CN111705006B (zh) | 表达新型冠状病毒s蛋白的口服重组酵母及其制备与应用 | |
AU636537B2 (en) | Improvement of the yield when disulfide-bonded proteins are secreted | |
WO1993018141A1 (en) | Thrombin receptor antagonists | |
AU619378B2 (en) | A signal peptide for the secretion of peptides in escherichia coli, a process for obtaining it, and its use | |
IL195854A (en) | Aminoacyl polypeptides - trna human synthesis used to regulate angiogenesis | |
CN110923183A (zh) | 产羊毛甾醇大肠杆菌菌株的构建方法 | |
JPH07184662A (ja) | 組換えアライグマポックスウイルスおよびネコ伝染性腹膜炎ウイルス疾患に対する効果的なワクチンとしてのそれらの使用 | |
CA2498636C (en) | Use of saccharomyces cerevisiae erg4 mutants for the expression of glucose transporters from mammals | |
KR20220023962A (ko) | 파브리병을 치료하기 위한 조성물, 디바이스 및 방법 | |
CN114934060A (zh) | 一种利用四氢嘧啶生产羟基四氢嘧啶的基因工程菌及其构建方法和应用 | |
KR20140094757A (ko) | 표적 유전자의 프로모터를 포함하는 카세트 및 상기 카세트를 이용한 유전자 조작 방법 | |
CN115247173A (zh) | 构建tmprss6基因突变的缺铁性贫血猪核移植供体细胞的基因编辑系统及其应用 | |
CN112272565A (zh) | 使用慢病毒基因构建体的递送的体内基因疗法 | |
CN109628487A (zh) | 一种利用转基因猪唾液腺制备人神经生长因子的方法 | |
CN113862207B (zh) | 一种改造菌株、其在制备促肠动力制剂中的应用及产品 | |
CN115161335B (zh) | 用于构建tardbp基因突变的als模型猪核移植供体细胞的基因编辑系统及其应用 | |
CN109321601B (zh) | Aqp5重组过表达载体及其构建方法和用途 | |
KR100902634B1 (ko) | 재조합 hmgb1 펩티드를 포함하는 핵산 전달 복합체 | |
CN114539425B (zh) | 一种提高线性多肽生物表达的方法 | |
KR20180100029A (ko) | 형질전환시킨 대장균 세포를 활용하여 시시엔5 단백질을 제조하는 방법 | |
CN107354172B (zh) | 重组表达载体及其构建方法和应用 | |
WO2021119782A1 (pt) | Microrganismos geneticamente modificados que realizam a produção heteróloga de versões modificadas da proteína surfactante lv-ranaspumina-1 (lv-rsn-1), as versões modificadas dessa proteína surfactante, os genes sintéticos que codificam essa proteína surfactante, os cassetes de expressão contendo esses genes sintéticos, e os vetores de expressão contendo esses genes sintéticos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20150904 |